Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 15 of the 53 sources its claims cite were checked for support.

Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis

Open access
Zayachkivska, Oksana, Havryluk, Olena, Hrycevych, Nazar, Bula, Nazar, Grushka, Oksana, Wallace, John L. · 2014 · PLoS ONE

Abstract

Non-erosive esophagitis is a chronic inflammatory condition of the esophagus and is a form of gastroesophageal reflux disease. There are limited treatment options for non-erosive esophagitis, and it often progresses to Barrett's esophagus and esophageal carcinoma. Hydrogen sulfide has been demonstrated to be a critical mediator of gastric and intestinal mucosal protection and repair. However, roles for H2S in esophageal mucosal defence, inflammation and responses to injury have not been reported. We therefore examined the effects of endogenous and exogenous H2S in rat models of non-erosive esophagitis. Mild- and moderate-severity non-erosive esophagitis was induced in rats through supplementation of drinking water with fructose, plus or minus exposure to water-immersion stress. The effects of inhibitors of H2S synthesis or of an H2S donor on severity of esophagitis was then examined, along with changes in serum levels of a pro- and an anti-inflammatory cytokine (IL-17 and IL-10, respectively). Exposure to water-immersion stress after consumption of the fructose-supplemented water for 28 days resulted in submucosal esophageal edema and neutrophil infiltration and the development of lesions in the muscular lamina and basal cell hyperplasia. Inhibition of H2S synthesis resulted in significant exacerbation of inflammation and injury. Serum levels of IL-17 were significantly elevated, while serum IL-10 levels were reduced. Treatment with an H2S donor significantly reduced the severity of esophageal injury and inflammation and normalized the serum cytokine levels. The rat models used in this study provide novel tools for studying non-erosive esophagitis with a range of severity. H2S contributes significantly to mucosal defence in the esophagus, and H2S donors may have therapeutic value in treating esophageal inflammation and injury.

Overview

CoChat Summary

## TL;DR

This rat study found that reducing endogenous hydrogen sulfide (H2S) worsened non-erosive esophagitis, while giving an H2S donor reduced esophageal injury and inflammation. The effect tracked with serum cytokines: IL-17 rose and IL-10 fell with worse disease, and the opposite pattern was seen with H2S treatment.

## Key findings

  • In healthy rats, inhibiting H2S synthesis caused only mild esophageal inflammation, with histological scores of 1–2 on a 0–9 scale, but no detectable mucosal damage.
  • In the fructose-induced hyperglycemia model, blood glucose increased from 5.8±0.2 to 6.4±0.2 mmol/L (p<0.05) and body weight increased by 8–10% versus controls; esophagitis severity increased and was worsened by PAG but not CHH.
  • In the hyperglycemia + water-immersion stress model, PAG again significantly increased severity, while NaHS significantly reduced esophagitis; L-Trp also reduced damage and, with NaHS, dramatically reduced histological changes and prevented hemorrhagic changes observed with PAG alone.
  • Across models, worse esophagitis was accompanied by higher IL-17 and lower IL-10; PAG or CHH decreased IL-10 and increased IL-17, while NaHS had the opposite effects.

## Methods

  • Rat experimental study using male Wistar rats (180–220 g), with 6–7 rats per group; animals were fasted 18 h before experiments and anesthetized with ketamine.
  • Two novel non-erosive esophagitis models were used: fructose-water for 28 days to induce hyperglycemia, and a more severe model combining hyperglycemia with 3.5 h water-immersion stress at 23°C.
  • Rats received vehicle, PAG (25 mg/kg), CHH (20 mg/kg), NaHS (100 µmol/kg), or L-Trp (50 mg/kg); esophageal injury was scored histologically and serum IL-10/IL-17 were measured by ELISA, with group comparisons by t-test or one-way ANOVA + Newman-Keuls.

## Limitations

  • Not stated in the paper.
  • Evident from the text: this is an animal study, so the findings may not directly translate to humans with non-erosive reflux disease.
  • Evident from the text: the study tested acute/short-term interventions and histological/cytokine outcomes, not long-term clinical endpoints.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0110688

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Treatment of healthy rats with inhibitors of hydrogen sulfide (H2S) synthesis produces negligible esophageal damage, but significantly alters serum levels of IL-10 and IL-17. Panel A: Small, but statistically significant changes in the histological score of lower esophageal integrity were observed following administration of either of the inhibitors of H2S synthesis (PAG, L-propargylglycine and CHH, O-carboxymethylhydroxylamine). The changes induced by the H2S inhibitors were limited to mild mucosa inflammation. Administration of the inhibitors of H2S synthesis also resulted in significant decreases in serum IL-10 levels, while the H2S donor, NaHS, had no effect. Small but significant increases in IL-17 levels were observed following administration of PAG, CHH and NaHS. Bars represent the mean ± SEM of at least 6 rats/group. *p<0.05 versus the vehicle-treated group (one-way ANOVA and Neuman-Keuls test).
Figure 1 Treatment of healthy rats with inhibitors of hydrogen sulfide (H2S) synthesis produces negligible esophageal damage, but significantly alters serum levels of IL-10 and IL-17. Panel A: Small, but statistically significant changes in the histological score of lower esophageal integrity were observed following administration of either of the inhibitors of H2S synthesis (PAG, L-propargylglycine and CHH, O-carboxymethylhydroxylamine). The changes induced by the H2S inhibitors were limited to mild mucosa inflammation. Administration of the inhibitors of H2S synthesis also resulted in significant decreases in serum IL-10 levels, while the H2S donor, NaHS, had no effect. Small but significant increases in IL-17 levels were observed following administration of PAG, CHH and NaHS. Bars represent the mean ± SEM of at least 6 rats/group. *p<0.05 versus the vehicle-treated group (one-way ANOVA and Neuman-Keuls test).CC BY · PubMed Central
Figure 2 Administration of an inhibitor of hydrogen sulfide (H2S) synthesis via cystathionine γ-lyase (L-propargylglycine; PAG) exacerbates esophageal injury/inflammation in hyperglycemic rats. Administration of PAG (25 mg/kg) resulted in a significant increase in the histological score of esophageal injury (panel A). PAG administration also reduced serum IL-10 and increased serum IL-17 levels. The effects of PAG on esophageal damage and serum IL-10 were reversed by co-adminstration of L-tryptophan (L-Trp). An inhibitor of another pathway of H2S synthesis (CHH; O-carboxymethylhydroxylamine; 20 mg/kg) had no effect on esophageal injury, but produced similar changes to serum IL-10 and IL-17 levels as were seen in PAG-treated rats. Panel C shows the irregular hyperemia, stasis (arrows) and perivascular diapedesis that was observed in rats that on the fructose-supplemented drinking water that were treated with PAG. Panel D illustrates that this treatment also resulted in localized detachments of the epithelium from the basement membrane and destructive changes to the epithelial plate (arrow). X200 (hematoxylin and eosin staining). Bars represent the mean ± SEM of at least 6 rats/group. *p<0.05 versus the vehicle-treated group; ψp<0.05 versus the corresponding group not treated with L-tryptophan (one-way ANOVA and Neuman-Keuls test).
Figure 2 Administration of an inhibitor of hydrogen sulfide (H2S) synthesis via cystathionine γ-lyase (L-propargylglycine; PAG) exacerbates esophageal injury/inflammation in hyperglycemic rats. Administration of PAG (25 mg/kg) resulted in a significant increase in the histological score of esophageal injury (panel A). PAG administration also reduced serum IL-10 and increased serum IL-17 levels. The effects of PAG on esophageal damage and serum IL-10 were reversed by co-adminstration of L-tryptophan (L-Trp). An inhibitor of another pathway of H2S synthesis (CHH; O-carboxymethylhydroxylamine; 20 mg/kg) had no effect on esophageal injury, but produced similar changes to serum IL-10 and IL-17 levels as were seen in PAG-treated rats. Panel C shows the irregular hyperemia, stasis (arrows) and perivascular diapedesis that was observed in rats that on the fructose-supplemented drinking water that were treated with PAG. Panel D illustrates that this treatment also resulted in localized detachments of the epithelium from the basement membrane and destructive changes to the epithelial plate (arrow). X200 (hematoxylin and eosin staining). Bars represent the mean ± SEM of at least 6 rats/group. *p<0.05 versus the vehicle-treated group; ψp<0.05 versus the corresponding group not treated with L-tryptophan (one-way ANOVA and Neuman-Keuls test).CC BY · PubMed Central
Figure 3 Administration of an inhibitor of hydrogen sulfide (H2S) synthesis via cystathionine γ-lyase (L-propargylglycine; PAG) increases esophageal injury/inflammation in hyperglycemic rats subjected to water-immersion stress. The exacerbation of histological damage by PAG (25 mg/kg) was reversed by co-administration of L-tryptophan (L-Trp). Both inhibitors of H2S synthesis significantly reduced serum IL-10 and increased serum IL-17, and co-administration of L-Trp diminished these effects. The H2S donor, NaHS, significantly increased IL-10 and reduced IL-17, and the combination of NaHS and L-Trp produced significantly greater changes in levels of these two cytokines. Bars represent the mean ± SEM of at least 6 rats/group. *p<0.05 versus the vehicle-treated group; ψp<0.05 versus the corresponding group not treated with L-Trp (one-way ANOVA and Neuman-Keuls test).
Figure 3 Administration of an inhibitor of hydrogen sulfide (H2S) synthesis via cystathionine γ-lyase (L-propargylglycine; PAG) increases esophageal injury/inflammation in hyperglycemic rats subjected to water-immersion stress. The exacerbation of histological damage by PAG (25 mg/kg) was reversed by co-administration of L-tryptophan (L-Trp). Both inhibitors of H2S synthesis significantly reduced serum IL-10 and increased serum IL-17, and co-administration of L-Trp diminished these effects. The H2S donor, NaHS, significantly increased IL-10 and reduced IL-17, and the combination of NaHS and L-Trp produced significantly greater changes in levels of these two cytokines. Bars represent the mean ± SEM of at least 6 rats/group. *p<0.05 versus the vehicle-treated group; ψp<0.05 versus the corresponding group not treated with L-Trp (one-way ANOVA and Neuman-Keuls test).CC BY · PubMed Central
Figure 4 Esophageal lesions with signs of nonerosive microscopic esophagitis induced by water-immersion stress after 28 days of consumption of fructose-supplemented drinking water. Panel A: Pretreatment with an inhibitor of cystathionine γ-lyase (L-propargylglycine; PAG) resulted in extensive esophageal inflammation, with profound submucosal leukocyte infiltration. Panel B: Macroscopic appearance of the lower esophagus of rat treated with PAG, with extensive perivascular hemorrhage. Panel C: Macroscopic appearance of lower esophagus of rat treated with PAG and L-tryptophan, the latter providing a protection against the detrimental effects of PAG.
Figure 4 Esophageal lesions with signs of nonerosive microscopic esophagitis induced by water-immersion stress after 28 days of consumption of fructose-supplemented drinking water. Panel A: Pretreatment with an inhibitor of cystathionine γ-lyase (L-propargylglycine; PAG) resulted in extensive esophageal inflammation, with profound submucosal leukocyte infiltration. Panel B: Macroscopic appearance of the lower esophagus of rat treated with PAG, with extensive perivascular hemorrhage. Panel C: Macroscopic appearance of lower esophagus of rat treated with PAG and L-tryptophan, the latter providing a protection against the detrimental effects of PAG.CC BY · PubMed Central
Figure 5 Summary of some of the key observations in models of mild, moderate and severe esophagitis in rats, and the effects of an inhibitors of hydrogen sulfide synthesis via cystathionine γ-lyase (L-propargylglycine; PAG). In healthy rats and in the rats with hyperglycemia- or hyperglycemia+stress-induced esophagitis, acute administration of PAG caused a significant exacerbation of esophageal inflammation. Serum levels of IL-10 decreased with the severity of esophagitis, and this was further enhanced in rats treated with PAG. In contrast, serum levels of IL-17 increased sharply in animal with esophagitis, in parallel with the severity of the disease, and administration of PAG caused further increases in all three models. *p<0.05 versus the corresponding vehicle-treated group (Student’s t-test).
Figure 5 Summary of some of the key observations in models of mild, moderate and severe esophagitis in rats, and the effects of an inhibitors of hydrogen sulfide synthesis via cystathionine γ-lyase (L-propargylglycine; PAG). In healthy rats and in the rats with hyperglycemia- or hyperglycemia+stress-induced esophagitis, acute administration of PAG caused a significant exacerbation of esophageal inflammation. Serum levels of IL-10 decreased with the severity of esophagitis, and this was further enhanced in rats treated with PAG. In contrast, serum levels of IL-17 increased sharply in animal with esophagitis, in parallel with the severity of the disease, and administration of PAG caused further increases in all three models. *p<0.05 versus the corresponding vehicle-treated group (Student’s t-test).CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 5 Not valid · 13 Not checked · 43 Own results and interpretations

28 more claims · 2 with their cited sources checked

Create a free account to see all 71 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 17
  • It may state two separate claims as one. 29

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 59 references

Research works printed but not linked: 4

  1. O Zayachkivska, 2009, Esophageal structural and functional reorganisation: role of endogenous defense mediators, Journal of Physiological Sciences, 59, 389
  2. VV Kozar, 2009, The state of the humoral component of immunity under conditions of metabolic syndrome with underlying hypoestrogenia and its farmacological correction. [in Ukrainian], Buk Med Herald, 13, 141
  3. OC Zayachkivska, 2006, Significance of NO-mediated mechanism in resistance of esophageal mucosa, Ukr Medical Almanac, 9, 48
  4. O Zayachkivska, 2010, Effect of proinflammatory cytokine-mediated mechanism of quality of gastrointestinal restitutio ad integrum, Annales Universitatis Mariae Curie-Skłodowska, 28, 211

Cited by

See all 34

Metadata

Authors
Zayachkivska, O., Havryluk, O., Hrycevych, N., Bula, N., Grushka, O., & Wallace, J. L.
Affiliations
  • Danylo Halytsky Lviv National Medical University (UA)
  • University of Calgary (CA)
Corresponding author
Wallace, John L.
Venue
PLoS ONE
Published
2014-10-21
Volume
9
Issue
10
Pages
e110688
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1977647501
Cited by
34
References
59
Citations by year
2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 7 · 2014: 1
FWCI
2.37
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Canadian Institutes of Health Research (12033, FRN-12033)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Hydrogen's biological and therapeutic effects
Keywords
hydrogen sulfide, gastroesophageal reflux disease, esophageal mucosal protection, water immersion stress, H2S donors, IL-17, IL-10, esophageal inflammation, neutrophil infiltration, esophageal edema, Barrett's esophagus
MeSH terms
Animals, Disease Models, Animal, Esophagitis, Gastroesophageal Reflux, Humans, Hydrogen Sulfide, Interleukin-10, Cytoprotection, Interleukin-17, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis. https://app.cochat.ai/papers/10.1371/journal.pone.0110688
The paper
Zayachkivska, O., Havryluk, O., Hrycevych, N., Bula, N., Grushka, O., & Wallace, J. L. (2014). Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis. PLoS ONE. https://doi.org/10.1371/journal.pone.0110688

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.